As of 2025-09-18, the Fair Value of Heron Therapeutics Inc (HRTX) is -0.15 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.21 USD, the upside of Heron Therapeutics Inc is -112.55%.
With the market price of 1.21 USD and our fair value calculation, Heron Therapeutics Inc (HRTX) is not a good investment. Investing in HRTX stocks now will result in a potential loss of 112.55%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -227.30 | -220.70 | -182.00 | -110.56 | -13.58 | -150.83 |
| YoY growth | -11.04% | 2.90% | 17.54% | 39.25% | 87.72% | 27.27% |
| Market Cap (mil) | 185.48 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | 27.27% |
| TTM earnings | -0.93 |